Newly Launched Replay Has Big Plans For Writing and Delivering ‘Big DNA’

Viral Vector Has 30 Times Capacity Of AAV

 
• By Andrew McConaghie
  
Herpes Simplex
One of the company's key technologies is a herpes simplex virus based gene therapy. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip